Female Technology (Femtech) Market to See Huge Growth by 2030

The last decade has been crucial for the adoption of digital technologies across the world. The introduction of mobile devices in the market has had a significant impact on modes of exchange and interaction with data. Traditionally, gender disparity has existed in the healthcare industry. However, the growth of the femtech market indicates that the industry is on its way to breaking some of the existing barriers. The increasing interest in femtech has kickstarted a start-up ecosystem focused on women’s health. This is a significant change since the market was considered a niche ten years ago, with Clue, the first app dedicated to femtech.

The global female technology market was estimated at $560.5 million in 2018 and is expected to witness a sharp growth of 17.18% during the forecast period 2019-2030.

Key USPs of the Report

Following are some of the key contents of the report:

• Funding Analysis
This chapter encompasses a description of the current funding landscape in the global femtech space, along with an assessment of the deal count of venture capital firms during the period 2018-2018. The chapter also assesses the state of private funding in the femtech market.

This chapter will enable the readers to obtain a better understanding of the way in which the funding scenario has evolved in the past few years and identify some of the key investors in the femtech market.

• Business Model Analysis
This chapter comprises information on the key business models deployed in the market by leading players

In addition, the report provides:

•   A detailed analysis and growth forecast (2019-2030) for different market segments
•   Recent developments and trends in the global market landscape
•   Factors promoting and inhibiting the market growth
•   Assessment of the funding scenario
•   Market trend assessment for pregnancy postpartum offerings

Scope of the Global Femtech Market

The purpose of the study is to enable the reader to gain a holistic view of the global femtech market, by each of the segments mentioned above.

The report constitutes an in-depth analysis of the global femtech market, including a thorough analysis of the products and services. The study also provides market and business-related information on various applications, region, and end users. The report considers mobile apps, connected devices, services, organic, and smart female hygiene products.

Key Companies in the Global Femtech Market

Some of the key players contributing to the global femtech market include ALYK, Inc., Aytu BioScience, Inc., Biowink GmbH, Bloomlife, CORA, Flo Health, Inc., Glow, Inc., Inne, Kasha, NaturalCycles Nordic AB, Ovia Health, Plackal Tech, Sustain Natural, The Flex Company, and Thinx, Inc.

Key Questions Answered in this Report:

•   How has the femtech market landscape evolved in the past decade?
•   What is the present status of femtech adoption globally?
•   Which are some of the leading players in the femtech market?
•   What are the different business models in the global femtech market?
•   What are some of the untapped opportunities for the femtech market?
•   How are the companies operating in the market generating revenue?
•   What are leading technologies which will witness increased adoption along with femtech?
•   What is the funding scenario of the global femtech market?
•   What is the state of femtech adoption in the Middle East and Latin America?
•   What are the existing barriers to technology adoption in different regions?
•   What are the influential trends in the fertility services market in femtech?
•   What are the regulatory guidelines concerning femtech apps and software in key regions?
•   What are some of the key features of apps available in the market?

Request a Sample - https://bisresearch.com/requestsample?id=1002&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog